Enhancing treatment of osteoarthritis knee pain by boosting expectancy: A functional neuroimaging study by Kong, Jian et al.
Enhancing treatment of osteoarthritis
knee pain by boosting expectancy:
A functional neuroimaging study
The Harvard community has made this
article openly available.  Please share  how
this access benefits you. Your story matters
Citation Kong, J., Z. Wang, J. Leiser, D. Minicucci, R. Edwards, I. Kirsch, A.
D. Wasan, et al. 2018. “Enhancing treatment of osteoarthritis knee
pain by boosting expectancy: A functional neuroimaging study.”
NeuroImage : Clinical 18 (1): 325-334. doi:10.1016/j.nicl.2018.01.021.
http://dx.doi.org/10.1016/j.nicl.2018.01.021.
Published Version doi:10.1016/j.nicl.2018.01.021
Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:37298429
Terms of Use This article was downloaded from Harvard University’s DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at http://
nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAA
Contents lists available at ScienceDirect
NeuroImage: Clinical
journal homepage: www.elsevier.com/locate/ynicl
Enhancing treatment of osteoarthritis knee pain by boosting expectancy: A
functional neuroimaging study
Jian Konga,b,⁎, Zengjian Wanga, Jaclyn Leisera, Domenic Minicuccia, Robert Edwardsc,d,
Irving Kirsche, Ajay D. Wasanf,g, Courtney Langa, Jessica Gerberb, Siyi Yua, Vitaly Napadowb,
Ted J. Kaptchuke, Randy L. Golluba,b,e
a Department of Psychiatry, Massachusetts General Hospital, Charlestown, MA, USA
bMGH/MIT/HMS Athinoula A. Martinos Center for Biomedical Imaging, Charlestown, MA, USA
c Department of Anesthesiology, Perioperative, and Pain Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA
d Department of Psychiatry, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA
e Program in Placebo Studies, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
fDepartment of Anesthesiology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
g Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
A R T I C L E I N F O
Keywords:
Knee osteoarthritis
Expectancy
Acupuncture
Reward
Resting state functional connectivity
A B S T R A C T
Objectives: Expectation can signiﬁcantly modulate pain and treatment eﬀects. This study aims to investigate if
boosting patients' expectancy can enhance the treatment of knee osteoarthritis (KOA), and its underlying brain
mechanism.
Methods: Seventy-four KOA patients were recruited and randomized to three groups: boosted acupuncture (with
a manipulation to enhance expectation), standard acupuncture, or treatment as usual (TAU). Each patient un-
derwent six treatments before being debriefed, and four additional treatments after being debriefed. The fMRI
scans were applied during the ﬁrst and sixth treatment sessions.
Results: We found signiﬁcantly decreased knee pain in the boosted acupuncture group compared to the standard
acupuncture or TAU groups after both six and ten treatments. Resting state functional connectivity (rsFC)
analyses using the nucleus accumbens (NAc) as the seed showed rsFC increases between the NAc and the medial
prefrontal cortex (MPFC)/rostral anterior cingulate cortex (rACC) and dorsolateral prefrontal cortex in the
boosted group as compared to the standard acupuncture group after multiple treatments. Expectancy scores after
the ﬁrst treatment were signiﬁcantly associated with increased NAc-rACC/MPFC rsFC and decreased knee pain
following treatment.
Conclusions: Our study provides a novel method and mechanism for boosting the treatment of pain in patients
with KOA. Our ﬁndings may shed light on enhancing outcomes of pharmacological and integrative medicines in
clinical settings.
1. Introduction
Non-speciﬁc eﬀects, such as the placebo eﬀect, play an important
role in medical practice (Finniss et al., 2010; Price et al., 2008). Under
certain circumstances, such as clinical trials, it presents challenges for
investigators. In other circumstances, it can enhance treatment out-
comes (Gollub and Kong, 2011; Weiss and Swede, 2016). While the
placebo eﬀect is well accepted, there is still much to learn about its
underlying mechanism and how to harness it in clinical settings.
It is believed that expectation plays an important role in non-spe-
ciﬁc eﬀects, particularly in the placebo eﬀect (Amanzio and Benedetti,
1999; Amanzio et al., 2013; Atlas et al., 2012; Tracey, 2010). In-
vestigators have found a well-accepted expectancy manipulation model
(Eippert et al., 2009; Hashmi et al., 2014; Kong et al., 2006, 2009a;
Wager et al., 2004), in which they surreptitiously reduce stimulus in-
tensity after placebo treatment to make subjects believe the treatment is
eﬀective, that can produce greater placebo eﬀects compared to verbal
suggestion alone (Colloca et al., 2008; Kong et al., 2013b; Voudouris
et al., 1990). In addition, this model can also enhance the eﬀect of
active treatments in healthy volunteers (Bingel et al., 2011; Kong et al.,
2009a). Nevertheless, few studies have applied the expectancy manip-
ulation model on the chronic pain patient population due to the
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diﬃculty in manipulating chronic pain intensity compared to experi-
mental pain. In this study, we ﬁrst applied an expectancy model using
experimental heat pain to enhance subjects' expectation of acupuncture
analgesia, and then tested whether this enhanced expectation improved
the treatment eﬀect of acupuncture on chronic pain caused by knee
osteoarthritis (OA).
Although still under investigation, one potential neural mechanism
by which enhanced expectation may lead to improved therapeutic
outcomes is through the engagement of the reward system in the brain.
Using pain as an example, the expectation of treatment eﬀect (pain
relief) can be rewarding and pleasurable, thus expectation, in the
context of treatment in clinics, can be regarded as a special case of
reward (Leknes and Tracey, 2008; Petrovic et al., 2005; Scott et al.,
2007; Yu et al., 2014b). In support of this hypothesis, neuroimaging
studies have found that the reward system, particularly the nucleus
accumbens (NAc), is involved in mediating placebo eﬀects in patients
with Parkinson's disease (de la Fuente-fernandex et al., 2002), depres-
sion (Mayberg et al., 2002), anxiety (Petrovic et al., 2005), and pain
(Scott et al., 2007; Yu et al., 2014b).
Literature suggests that two neurotransmitter systems are involved
in the pain modulation of reward expectation and motivation: the do-
pamine system increases motivation, whereas the opioid system inﬂu-
ences motivation indirectly by modulating subjective feelings of pain
and reward (Berridge, 2007; Navratilova et al., 2015a; Navratilova and
Porreca, 2014). Studies also found that the two systems are closely
related neuroanatomically, and interact in complex ways (Leknes and
Tracey, 2008). The brain regions that are particularly well-situated to
mediate interactions between the two systems are the NAc (Schmidt
et al., 2014; Smith and Berridge, 2007; Szechtman et al., 1981; Wei
et al., 2004; Zubieta et al., 2001), anterior cingulate cortex (ACC), and
medial prefrontal cortex (MPFC) (Hare et al., 2008; Navratilova et al.,
2015a, 2015b; Tuominen et al., 2012).
Recent studies have demonstrated that resting state functional
connectivity (rsFC) can provide information about the intrinsic func-
tional organization of the brain (Fox and Raichle, 2007; Vincent et al.,
2006), improve our understanding of pain modulation (Kong et al.,
2013a), and predict treatment outcomes (Tetreault et al., 2016). In this
study, we investigated 1) if boosted expectancy of acupuncture an-
algesia for experimental pain can enhance acupuncture treatment for
knee OA and 2) how boosted expectancy modulates rsFC of the NAc. We
chose acupuncture treatment of chronic pain because it provides an
excellent model for studying the modulation eﬀect of expectation.
Studies indicate that the non-speciﬁc eﬀect of acupuncture is robust
(Cherkin et al., 2009; Vickers et al., 2012). Furthermore, acupuncture is
gaining popularity due to its total clinical eﬀectiveness (Berman et al.,
2010; Vickers and Linde, 2014), and rarity of adverse eﬀects (Melchart
et al., 2004; White et al., 2001). We hypothesized that acupuncture
with boosted expectancy would 1) produce greater clinical improve-
ments than acupuncture alone and 2) increase rsFC between the NAc
and rACC/MPFC.
2. Materials and methods
2.1. Subjects
Subjects with knee OA were recruited. Experiments were conducted
with approval from the Massachusetts General Hospital Institutional
Review Board and with the written, informed consent of each partici-
pant. All subjects agreed to allow their data to be analyzed. The study
was registered at clincaltrials.gov (NCT#: 01040754).
Inclusion criteria included: between 40 and 70 years of age; met the
Classiﬁcation Criteria of the American College of Rheumatology for
osteoarthritis of the right and/or left knee; radiographic evidence of
Grade 2 or 3 knee OA using the Kellgren-Lawrence Scale. Exclusion
criteria were: interventional procedure for knee pain within two
months, including corticosteroid injections to the knee; intent to
undergo surgery during the time of involvement in the study; presence
of a cardiovascular, neurological or psychiatric disorder; additional
pain disorder with severity greater than knee OA pain; pregnancy;
acupuncture treatment within one year; diﬃculties reading, speaking or
understanding English. All subjects were told to maintain their baseline
medications and other treatments for their knee OA during the duration
of the study. They were prompted to report any changes in treatment,
including frequency of prn medications, at each study visit.
2.2. Experimental procedure
Subjects were stratiﬁed by gender and the most aﬀected knee, and
then randomized into one of three groups: boosted acupuncture, stan-
dard acupuncture, or treatment as usual (TAU control) at the beginning
of session 2 (Supplementary Fig. 1). The randomization table was cre-
ated by a study biostatistician using the R program. Both acupuncture
groups received identical acupuncture treatments for four weeks (2
times/week for the ﬁrst two weeks, and 1 time/week for the last two
weeks). After a mid-point evaluation and debrieﬁng, patients received
an additional 4 weeks of acupuncture (1 time/week).
All subjects in the two acupuncture groups participated in a total of
13 study visits, including the baseline training and clinical assessment
(session 1), ﬁrst fMRI scan session including the ﬁrst acupuncture
treatment (session 2), four acupuncture treatments (session 3–6),
second fMRI scan session including the sixth acupuncture treatment
(the procedure was identical to the ﬁrst MRI scan) and debrieﬁng at the
end of the session in the boosted acupuncture group (session 7), mid-
point clinical assessment (session 8), 4 additional acupuncture treat-
ments over the course of a month (session 12), and ﬁnal clinical as-
sessment (session 13) (Supplementary Fig. 1). In the boosted
acupuncture group, an expectancy manipulation similar to our previous
studies (Hashmi et al., 2014; Kong et al., 2006, 2009a, 2009b) was
applied during the fMRI scan sessions (during treatment one and
treatment six) to enhance subjects' positive expectation of pain reduc-
tion with acupuncture treatment.
The TAU group participated in 5 visits, including the baseline
training and assessment, ﬁrst fMRI scan, second fMRI scan, midpoint
assessment, and a ﬁnal assessment. They followed the exact timing for
the acquisition of behavioral, clinical and imaging data, but without
any treatment (Supplementary Fig. 1).
Session 1 was a training and baseline clinical outcome measurement
session. Following being screened and signing the consent form, all
subjects completed the Knee Injury and Osteoarthritis Outcomes Score
(KOOS) to measure their knee pain and function.
A 1× 3 grid was drawn on the medial surface of the aﬀected knee,
avoiding the patella. Then, calibrated thermal heat pain stimuli were
delivered to the medial side of the aﬀected knee using a PATHWAY
system with a 3 cm×3 cm probe (Egorova et al., 2015b; Egorova et al.,
2015c). Each stimulus was initiated at a 32 °C baseline and increased to
a target temperature that was presented for 12 s, including 2.5 s to ramp
up and ramp down. The inter-stimulus interval ranged from 24 to 30 s.
Subjects rated their pain for each stimulus during the inter-stimulus
interval using a 0–20 Gracely Sensory Box scale (Gracely et al., 1978a,
1978b).
Similar to our previous studies (Hashmi et al., 2014; Kong et al.,
2006, 2009a, 2009b), subjects ﬁrst experienced one ascending series of
calibrated heat stimuli. The ﬁrst stimulus of each ascending series was
initiated from a target temperature of 38°C. Subsequent stimuli were
increased by 1 °C to 52 °C or to the subject's tolerance: a rating of ~17
(Very Intense) on the Gracely Scale. Two temperatures, one that elicited
low ratings (5–7; mild to moderate) and one that elicited high ratings
(14–15; strong) were selected for each subject. Once the two tem-
peratures for a subject were determined, he or she was tested for rating
response consistency. Random sequences of 4 low and 4 high intensity
noxious stimuli were administered. The temperatures were further ad-
justed as needed. Subjects had to consistently rate the high intensity
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stimuli as greater than the low intensity stimuli to continue in the
study.
Session 2 was an fMRI scan session that included a resting state fMRI
scan applied at the beginning of the session, followed by an expectancy
manipulation in the boosted group and ﬁrst acupuncture treatment for
those in the acupuncture groups.
2.3. Expectancy manipulation
Subjects' expectation that acupuncture treatment would relieve
their experimental pain was manipulated in the boosted group using
similar methods as employed in our previous studies in healthy subjects
and subjects with chronic pain due to knee OA (Hashmi et al., 2014;
Kong et al., 2006, 2009a, 2009b). At the beginning of the session,
subjects were given a scripted explanation that a person's responses to
acupuncture can be positive or neutral, and that this response tends to
remain consistent over time. They were also told that previous studies
had shown that if acupuncture relieved pain induced by experimental
heat that would indicate they were more likely to have a good outcome
for their endogenous knee pain over the course of the treatments.
Neither of these statements is in fact known to be true. This verbal
suggestion is one component of the manipulation to enhance expecta-
tion for analgesia. The conditioning aspect of the expectancy manip-
ulation consisted of telling subjects that they would receive identical
heat pain stimuli before and after treatment, but in reality, after
treatment we surreptitiously lowered heat pain temperatures in the
boosted group to reduce their rating to “faint to weak” and hence give
subjects an unmistakable experience of profound analgesia (Fig. 1A).
Subjects in the standard acupuncture group experienced the same
pain as the boosted group, but were told the truth at the beginning of
the session and reminded before the post-treatment pain application
right after acupuncture treatment that we would administer pain sti-
muli of a lower intensity so that we could investigate their brain re-
sponse to a diﬀerent level of pain (Fig. 1A). As a result, they should feel
less pain, but this has no relation to the treatment eﬀect of acupuncture.
The same information was given to the TAU control group. Identical
procedures were repeated in the sixth treatment, during the second MRI
scan for each group (Fig. 1A).
All subjects rated their expectation of how acupuncture treatment
would modify the intensity of the pain they experienced in response to
calibrated, experimental heat pain stimuli and endogenous knee pain at
baseline (session 1), before and after expectancy manipulations during
the ﬁrst and second scans, and at the end of the study (session 13)
(Fig. 1A). They used the same 0–10 visual analogue scale (0 indicates
“does not work at all”, and 10 indicates “complete pain relief”), labeled
explicitly to assess expected relief of exogenous heat pain or en-
dogenous chronic knee pain.
To explore whether the eﬀects of this manipulation to boost ex-
pectation of pain relief would persist if subjects were aware of what we
did, we debriefed the boosted subjects at the end of the second scan
(sixth treatment, session 7). To debrief the subjects, we read them a
script explaining that we reduced the heat pain stimuli intensity after
Fig. 1. A: Details of expectancy manipulation paradigm. We
ﬁrst used a marker to draw three boxes identical in size on
the medial side of the most aﬀected knee. Then, we placed
the thermal probe in one of the boxes at a time. One box
received random pain (RP), consisting of four moderate in-
tensity pain stimuli and four low intensity pain stimuli in a
random order. RP stimuli were applied to ensure subjects
could consistently rate pain stimuli. The other two boxes
received identical pain (IP) sequences consisting of 6 iden-
tical moderate pain stimuli. After acupuncture treatment
(boosted or standard) or waiting for 20min (TAU group),
decreased identical pain sequences (dIP), consisting of 6
identical low intensity pain stimuli, were applied on all the
two IP boxes in the same order as above. Those in the
boosted acupuncture group were informed they were going
to receive identical pain stimuli similar to before the treat-
ment to test the analgesic eﬀect of acupuncture. Those in the
other groups (standard and TAU) were informed they were
going to receive lowered intensity stimuli to investigate
brain responses to diﬀerent levels of pain. After this ma-
nipulation, patients in the boosted acupuncture group felt
acupuncture signiﬁcantly relieved the heat pain. Expectancy
scores were collected before and after expectancy manip-
ulation. B: Locations of 6 acupoints. C: Stimulation para-
meters applied for acupuncture treatment. This procedure
was applied twice. S, needle stimulation.
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their treatment to give them an unmistakable experience of analgesia.
We also assured them that if they experienced clinical improvements in
knee pain, this pain relief was real and might well continue.
2.4. Acupuncture administration
All subjects in the two acupuncture groups received 10 identical
acupuncture treatments over two months according to the following
schedule: 2 times/week for the ﬁrst two weeks and 1 time/week for the
last six weeks.
The 6 acupoints selected for treatment were ST35, Xi yian (extra
point), GB34, SP9, GB39 and SP6 (Fig. 1B). This set of acupuncture
points are most commonly used in clinical treatment trials for knee pain
(Berman et al., 2004; Scharf et al., 2006; Witt et al., 2005). In subjects
with bilateral knee pain, the treatments were applied to the knee with
the most pain or the knee the subject believed needed more attention.
We followed identical procedures as in our previous experiment
(Chen et al., 2015; Chen et al., 2014; Egorova et al., 2015a; Spaeth
et al., 2013). During acupuncture treatment, the acupuncturist stimu-
lated one point at a time in a predetermined order, each for 10 s with
30-second breaks between each acupoint (Fig. 1C). Each acupoint was
stimulated 4 times in a treatment. We randomized the speciﬁc starting
acupoint across subjects, but held it constant throughout all sessions for
each individual subject. For consistency, we kept leg position, acupoint
location, and needling parameters (1–2 cm depth, approximately 120
rotations per minute, and moderate deqi sensations on a 0–10 scale)
constant across the two groups. In the fMRI sessions, there were two 9-
min acupuncture scans per treatment followed by an assessment with
the Massachusetts General Hospital Acupuncture Sensation Scale
(MASS) (Kong et al., 2007a; Spaeth et al., 2013).
2.5. Clinical outcomes and data analysis
2.5.1. Knee injury and Osteoarthritis Outcome Score (KOOS)
We measured clinical outcomes using the KOOS (Roos and Toksvig-
Larsen, 2003) measured at baseline, the midpoint, and the end of the
study. KOOS is comprised of 5 subscales: 1) pain, 2) other symptoms, 3)
function in daily living (ADL), 4) function in sports and recreation, and
5) knee-related quality of life (QOL). Each subscale allows for the cal-
culation of a normalized score, with 0 denoting the most extreme
symptoms/pain and 100 denoting no symptoms/pain (Roos and
Toksvig-Larsen, 2003). Based on previous studies (Berman et al., 2004;
Chen et al., 2015; Egorova et al., 2015a; Spaeth et al., 2013), we se-
lected the KOOS pain subscale as our primary outcome measure, and
other subscales as our secondary outcome measures. Trained research
assistants administered the KOOS to all subjects.
Clinical outcome analysis was performed using SPSS 18.0 Software
(SPSS Inc., Chicago, IL, USA). The ANCOVA analysis was applied to
compare the change in KOOS pain subscales and other scores across the
three groups respectively. Age and gender were included in the model.
ANOVA analysis was applied to compare the expectancy scores mea-
sured at diﬀerent points. A post hoc analysis (Sidak) was applied to
explore post-hoc between-group diﬀerences. Multiple regression ana-
lyses were applied to explore the association between the expectancy
score, resting state functional connectivity changes, and KOOS pain
subscore changes following treatments across all patients who received
acupuncture treatments.
2.6. fMRI data acquisition and data analysis
Whole brain imaging was performed with a 3-Tesla Siemens MRI
system. For the BOLD scans during resting state (6 min), the acquisition
included 47 slices with a thickness of 3mm, a TR of 3000ms, a TE of
30ms, ﬂip angle of 85 degrees, ﬁeld of view of 216mm2 and a 3× 3-
mm in-plane spatial resolution. Subjects were instructed to keep their
eyes opened during the resting fMRI scan. Structural images were also
obtained by a MP-RAGE sequence (TR=2530ms, TE= 1.69, echo
time=9.8ms, ﬂip angle of 7, ﬁeld-of-view of 256mm, slice thick-
ness= 1mm). Due to the characteristics of knee OA, patients usually
do not experience knee pain while they are lying still in the scanner.
Similar to our previous studies (Liu et al., 2016; Wang et al., 2016
#4392; Song et al., 2017; Tao et al., 2017; Tao et al., 2016; Wang et al.,
2017), functional connectivity analysis was carried out by applying a
seed-based approach using the CONN toolbox (Whitﬁeld-Gabrieli and
Nieto-Castanon, 2012) [http://www.nitrc.org/projects/conn]. Bilateral
NAc templates extracted from the IBASPM (atlas71) using WFU-Pick
Atlas software (Maldjian et al., 2003) were selected as the seed (region
of interest).
The preprocessing of fMRI data was performed using Statistical
Parametric Mapping (SPM8) (Wellcome Department of Cognitive
Neurology, University College, London, UK) in MATLAB (Mathworks,
Inc., Natick, Massachusetts) incorporated into the CONN toolbox. The
preprocessing steps included slice-timing correction, realignment, co-
registration to subjects' respective structural images, which was used to
normalize images to the standard Montreal Neurological Institute
template, and smoothing with an 8mm full width at half maximum
(FWHM) kernel. In addition to these steps, we employed segmentation
of gray matter, white matter, and cerebrospinal ﬂuid (CSF) areas for the
removal of temporal confounding factors (white matter and CSF)
(Whitﬁeld-Gabrieli and Nieto-Castanon, 2012). Band-pass ﬁltering was
performed with a frequency window of 0.008–0.09 Hz.
To eliminate head motion and artifacts, we identiﬁed outlier time
points in the motion parameters and global signal intensity using ART
(http://www.nitrc.org/projects/artifact_detect). For each subject, we
treated images (time points) as outliers if composite movement from a
preceding image exceeded 0.5 mm, or if the global mean intensity
was> 3 standard deviations from the mean image intensity for the
entire resting scan. Outliers were included as regressors in the ﬁrst level
general linear model along with motion parameters. Four subjects were
excluded due to over-determined models (no degrees of freedom for this
subject) as suggested by ART.
First-level correlation maps were produced by extracting the re-
sidual BOLD time course from each NAc seed and by computing
Pearson's correlation coeﬃcients between that time course and the time
courses of all other voxels in the brain. Correlation coeﬃcients were
Fisher transformed into ‘Z’ scores to increase normality and allow for
improved second-level General Linear Model analyses.
Whole brain second level group analysis was applied using two
sample t-tests to compare the NAc functional connectivity changes be-
tween diﬀerent groups. Similar to our previous studies (Wang et al.,
2017; Liu et al., 2016; Wang et al., 2016; Song, 2017; Tao et al., 2017;
Tao et al., 2016), a threshold of voxel-wise p < 0.005 uncorrected and
cluster-level p < 0.05 family-wise error (FWE) correction was applied
for all fMRI data analysis.
3. Results
3.1. Clinical outcomes
Of the 74 subjects who participated in the study, twenty subjects
were excluded (Supplementary Fig. 1). Five subjects chose to leave the
study because they decided their schedules were incompatible. One
subject was excluded due to an atypical pain response; he was in-
sensitive to even the highest temperature setting on the MEDOC. Six
subjects left the study after discovering they were claustrophobic at the
time of the scan. Two subjects decided they did not want their knees
exposed to any heat following their screening visit. Three subjects
decided not to participate after learning they would be in the waitlist
group. Finally, three subjects were lost to follow up before their ﬁrst
MRI scans. Twelve of the twenty subjects who dropped had been ran-
domized, with ﬁve assigned to the boosted acupuncture group, ﬁve
assigned to the TAU group, and two assigned to the standard
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acupuncture.
There was no systematic reason that inﬂuenced subjects to with-
draw from the study and there was no signiﬁcant diﬀerence in dropout
rates among the three groups (p=0.29). 54 subjects aged 60.2+/-
7.5 years (19 boosted acupuncture, 18 standard acupuncture, and 17
TAU controls) completed both fMRI scans. Four subjects (1 standard
acupuncture and 3 TAU controls) were excluded from the rsFC analysis
due to excessive motion. Four additional subjects' KOOS data was
missing (2 boosted and 2 TAU controls) from the measurements taken
at midpoint. The ﬁnal analysis was applied only to subjects with com-
plete data and thus 46 subjects were included in the fMRI and KOOS
pain score data analysis.
The ANCOVA analysis of change in the KOOS pain subscale scores at
baseline and midpoint showed signiﬁcant diﬀerences among the three
groups when gender and age were controlled for, F(2,41)= 6.97,
p=0.002 (Fig. 2). Post hoc analysis indicated that the boosted acu-
puncture signiﬁcantly decreased pain compared to standard acu-
puncture (p=0.005) and TAU control groups (p=0.015). In addition,
we also found signiﬁcant diﬀerences between the boosted acupuncture
and standard acupuncture groups in KOOS Sport subscale scores, and
between boosted acupuncture and TAU groups. There was no sig-
niﬁcant diﬀerence between the standard acupuncture and TAU control
(Table 1).
The ANCOVA analysis of change in KOOS pain subscale scores at
baseline and the end of the study (after 10 treatments) also showed
signiﬁcant diﬀerences among the three groups, F(2,41)= 5.56,
p=0.005 (Fig. 2). Post hoc analysis indicated that the boosted treat-
ment signiﬁcantly decreased pain compared to standard acupuncture
(p=0.027) and TAU control groups (p=0.005). In addition, we also
found signiﬁcant diﬀerences between the boosted acupuncture and
TAU group in KOOS ADL and QOL subscale scores. There were no
signiﬁcant diﬀerences between standard acupuncture and TAU control
groups (Table 1).
Subjects' expectancy of acupuncture analgesia in response to ex-
perimental heat pain and endogenous knee pain were measured at
baseline, before and after expectancy manipulation during the ﬁrst and
second scans, and at the end of the study (Table 2). We found sig-
niﬁcant group diﬀerences in expectancy scores following the ex-
pectancy manipulation during the ﬁrst scan for both heat pain
(F(2,42) = 7.04, p= 0.002; post hoc analysis: Boosted vs Standard
Acupuncture p=0.041, Boosted vs TAU p=0.003; Standard vs TAU
p=0.477) and knee pain (F(2,42) = 4.46, p=0.018; post hoc analysis:
Boosted vs Standard Acupuncture p=0.025, Boosted vs TAU
p=0.091; Standard vs TAU p=0.99). There was no signiﬁcant dif-
ference between groups in expectancy scores at other time points
(Table 2).
To explore the general association between the expectancy at the
beginning of treatment can inﬂuence clinical outcomes after multiple
treatments, we also performed a regression analysis between the ex-
pectancy scores for how treatment impacts endogenous knee pain
measured after the ﬁrst expectancy manipulation, and clinical im-
provement (change in KOOS pain score) after six and ten treatments.
Since the two acupuncture groups received identical acupuncture
treatment, to increase the power, we pooled the data from the two
groups. We found a signiﬁcant association between expectancy scores
and clinical improvements (p=0.04) (Fig. 3A) after six treatments, but
not after ten treatments (p=0.15).
Based on the medication logs, only one subject (from the standard
acupuncture group) reported a medication change. That subject
Fig. 2. KOOS pain score changes measured at the midpoint and the end of the study compared to baseline (mean ± SE).
Table 1
Demographics and KOOS scores (mean+ SD). Higher KOOS scores indicate less pain.
ADL, activities of daily living. QOL, Quality of Life. TAU, treatment as usual.
Characteristic Boosted Acu Standard Acu TAU
Age 61.3 ± 6.9 61.2 ± 7.7 60.1 ± 7.1
N (Female/Male) 17 (9/8) 17 (10/7) 12 (8/4)
Baseline
KOOS Pain 57.7 ± 13.9 68.6 ± 13.2 63.7 ± 15.6
KOOS Symptoms 57.6 ± 15.2 64.1 ± 12.4 68.7 ± 16.9
KOOS ADL 64.4 ± 18.2 75.7 ± 17.6 76.1 ± 16.3
KOOS Sport 35.3 ± 25.3 52.1 ± 25.1 43.3 ± 26.5
KOOS QOL 32.7 ± 18.9 43.4 ± 19.2 46.9 ± 17.4
Midpoint after 6 treatments
KOOS Pain 70.1 ± 15.6 66.0 ± 13.4 61.3 ± 15.2
KOOS Symptoms 64.7 ± 14.8 62.2 ± 14.5 65.2 ± 19.2
KOOS ADL 73.5 ± 15.0 75.7 ± 12.8 71.2 ± 15.7
KOOS Sport 52.6 ± 25.9 50.9 ± 19.0 49.2 ± 23.1
KOOS QOL 47.1 ± 16.8 51.8 ± 10.5 50.0 ± 17.5
Endpoint after 10 treatments
KOOS Pain 71.4 ± 14.7 69.9 ± 15.5 60.4 ± 14.7
KOOS Symptoms 66.0 ± 17.2 65.5 ± 19.4 64.3 ± 19.3
KOOS ADL 74.7 ± 15.1 79.6 ± 16.0 69.7 ± 16.5
KOOS Sport 44.7 ± 25.4 59.1 ± 25.6 46.2 ± 28.7
KOOS QOL 47.4 ± 19.1 54.0 ± 17.8 47.4 ± 16.7
Change between baseline and
midpoint
KOOS Pain 12.4 ± 12.4 −2.6 ± 11.6⁎ −2.3 ± 14.4⁎
KOOS Symptoms 7.1 ± 14.2 −1.9 ± 12.8 −3.6 ± 11.9
KOOS ADL 9.2 ± 13.5 0.0 ± 11.7 −4.9 ± 12.1⁎
KOOS Sport 17.4 ± 23.7 −1.2 ± 19.7⁎ 5.8 ± 18.8
KOOS QOL 14.3 ± 14.6 8.5 ± 15.3 3.1 ± 17.8
Change between baseline and
endpoint
KOOS Pain 13.9 ± 14.4 1.3 ± 14.9⁎ −3.2 ± 7.4⁎
KOOS Symptoms 8.4 ± 16.8 1.5 ± 16.7 −4.5 ± 11.3
KOOS ADL 10.3 ± 15.9 3.9 ± 15.2 −6.4 ± 6.4⁎
KOOS Sport 9.4 ± 34.4 7.1 ± 19.5 2.9 ± 13.9
KOOS QOL 14.7 ± 13.6 10.7 ± 17.6 0.5 ± 15.6⁎
⁎ Indicates signiﬁcant diﬀerence in change when compared to boosted acupuncture
group.
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developed a toothache and took ibuprofen as recommended by her
dentist. The subject's KOOS pain score was 72.2 before the ﬁrst scan and
72.2 after the sixth treatment, thus she showed no improvement as
measured by the KOOS pain scale.
3.2. Functional connectivity results
A comparison of NAc rsFC changes (‘post’ minus ‘pre’) between the
boosted and standard acupuncture treatments revealed a signiﬁcant
increase of rsFC between the NAc and left middle cingulate cortex
(MCC)/paracentral gyrus (PaCG)/postcentral gyrus (PoCG), left medial
prefrontal cortex (MPFC)/rostral anterior cingulate cortex (rACC), right
PoCG and left dorsolateral prefrontal cortex (DLPFC) in the boosted
acupuncture group (Table 3, Fig. 3B). Boosted acupuncture treatment
produced greater rsFC increases between the NAc and left ventral
medial prefrontal cortex (vMPFC) compared to the TAU group
(Table 3). There were no NAc rsFC diﬀerences in any brain region be-
tween the standard acupuncture and TAU groups at the threshold we
set.
Given our hypothesis of the important role of NAc and MPFC/rACC
in the rewarding eﬀect of pain relief (Navratilova et al., 2015a), we also
extracted the cluster value of NAc – MPFC/rACC rsFC increases (scan 2
– scan 1), and explored if the expectancy score at the beginning of the
treatment can modulate the NAc – MPFC/rACC resting state functional
connectivity changes after multiple acupuncture treatments by calcu-
lating the association between the two. Additionally, we also in-
vestigated the association between the NAc – MPFC/rACC resting state
functional connectivity changes and the corresponding KOOS pain
changes after repeated treatments, including age and gender as cov-
ariates. Since our aim is to explore the general relationship, rather than
a speciﬁc treatment group, between resting state functional
connectivity, expectancy scores at the beginning of the treatment, and
clinical outcome changes, it is appropriate to pool the data from the two
groups that received identical treatment in order to increase power. We
found a signiﬁcant association between 1) the NAc – MPFC/rACC rsFC
increases and the expectancy scores (p=0.002) (Fig. 3C) and 2) the
NAc – MPFC/rACC rsFC increases and KOOS pain rating increases
(clinical improvement) after six treatments (p=0.04).
4. Discussion
In this study, we explored the feasibility of enhancing acupuncture
treatment on knee OA using a well-tested expectancy manipulation
model. We found that boosted acupuncture with enhanced expectation
of pain relief can signiﬁcantly increase acupuncture's therapeutic eﬀect
on knee pain compared to standard acupuncture which received iden-
tical acupuncture treatment as boosted acupuncture group. We also
found that boosted expectation signiﬁcantly enhanced the rsFC of the
NAc with rACC, MPFC, DLPFC, and paracentral and postcentral gyri.
Expectancy scores at the beginning of the study were signiﬁcantly as-
sociated with NAc-rACC/MPFC rsFC increases and with KOOS pain
score increases (clinical improvement) after repeated acupuncture
treatments across all subjects who received acupuncture treatments.
We found for the ﬁrst time that boosted expectation of pain relief to
experimental heat pain due to an active treatment (acupuncture) can be
transferred to chronic knee pain to enhance clinical outcomes. Knee OA
is a major age-related public health problem and a leading cause of
long-term pain and disability (Murphy et al., 2008; Murray et al.,
2012). Pharmacological treatment of knee OA is often ineﬀective with
unwanted and dangerous side eﬀects (Berman et al., 2004; Felson et al.,
2000). Arguably, acupuncture may be a promising treatment option for
knee OA due to its eﬀectiveness in relieving pain (Berman et al., 2004;
Table 2
Expectancy (mean (SD)) at diﬀerent time points across three treatment groups (n=46).
Modalities Groups Baseline Visit First Scan Second Scan Last Visit
Pre Post Pre Post
Heat pain expectancy Boosted Acu 6.1 (1.8) 5. 8 (2.8) 7.5 (1.8) 6.1 (2.8) 7.2 (2.4) 5.2 (3.2)
Standard Acu 5.6 (2.1) 5.2 (2.9) 5.4 (2.7)⁎ 5.2 (2.9) 5.4 (3.2) 4.5 (2.6)
TAU 6.1 (2.6) 4.5 (3.3) 4.1 (2.9)⁎ 5.5 (2.6) 5.1 (2.3) 5.3 (2.9)
Knee pain expectancy Boosted Acu 6.9 (1.8) 6.7 (2.1) 7.9 (1.8) 6.9 (2.3) 7.5 (2.2) 6.4 (2.7)
Standard Acu 6.2 (2.1) 5.3 (2.8) 5.7 (2.5)⁎ 5.4 (2.8) 5.9 (2.7) 5.6 (2.6)
TAU 6.1 (1.4) 6.1 (2.8) 5.9 (2.7)⁎ 5.9 (2.3) 5.4 (2.1) 5.8 (2.4)
⁎ Indicates a signiﬁcant diﬀerence in change when compared to boosted acupuncture group.
Fig. 3. A. Partial plot showing the positive association between the expectancy scores after the expectancy manipulation in session 2 (x axis) and KOOS pain increases (clinical
improvement) after six acupuncture treatments (y axis), including age and gender as covariates (p=0.04) across the two acupuncture groups (solid dot indicates standard acupuncture
group, hollow dot indicates boosted acupuncture group). B. Representative brain regions showed a signiﬁcant rsFC increase in boosted acupuncture as compared to standard acupuncture
(voxel-wise p < 0.005, and cluster-level p < 0.05 FWE corrected). C. The scatter plot represents the partial plot showing the positive association between the expectancy score (x axis)
after expectancy manipulation in session 2 and NAc and rACC/MPFC connectivity changes (y axis), including age and gender as covariates (p=0.002). MCC, middle cingulate cortex;
rACC, rostral anterior cingulate cortex; MPFC, medial prefrontal cortex.
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Hinman et al., 2014a; Mavrommatis et al., 2012; Scharf et al., 2006;
Suarez-Almazor et al., 2010; Witt et al., 2005), and the rarity of adverse
eﬀects (MacPherson et al., 2001; Melchart et al., 2004; Ochi, 2013;
White et al., 2001). Our ﬁndings will shed new light on how to enhance
the acupuncture treatment of this highly prevalent disorder and other
chronic pain disorders.
We found enhanced clinical improvement even after being de-
briefed, which persisted at least for one month after being debriefed.
This ﬁnding is consistent with a previous study investigating the post-
debrieﬁng eﬀect using experimental pain (Wickless and Kirsch, 1989).
It is also consistent with a more recent study suggesting that placebo
analgesia to experimental pain may be produced by prior conditioning
rather than by current expected pain relief (Schafer et al., 2015). Our
results suggest that once a treatment is thought to be eﬀective, whether
there was manipulation to enhance expectation or not, experiencing the
improvement may produce a conditioning-like eﬀect.
When we combined all subjects who received acupuncture, subjects'
expectation of acupuncture to treat their knee pain after the ﬁrst
treatment was signiﬁcantly associated with clinical improvement after
six acupuncture treatments, implying the important role of expectation
in acupuncture treatment. This result is consistent with clinical studies
suggesting that baseline expectancy is associated with pain improve-
ment after acupuncture treatment (Kalauokalani et al., 2001; Linde
et al., 2007). For instance, in a pooled analysis of four trials of acu-
puncture in patients with migraine, tension-type headache, chronic low
back pain, and knee OA (Linde et al., 2007), Linde and colleagues found
a signiﬁcant association between clinical improvement and greater
expectations for a good outcome. In another study investigating the
eﬀects of acupuncture and communication style in patients with knee
OA (Suarez-Almazor et al., 2010), investigators found that there was no
signiﬁcant diﬀerence between the real and sham acupuncture groups,
while high expectation communication styles (using positive utterances
such as “I think this will work for you”) did have a small but signiﬁcant
eﬀect on pain reduction and satisfaction in knee pain control as com-
pared to a neutral expectation communication style (treatment con-
veyed with statements of uncertainty such as “this may or may not work
for you”). Nevertheless, some clinical trials failed to ﬁnd the association
between expectancy ratings and therapeutic eﬀects of acupuncture on
chronic pain (Sherman et al., 2010; Thomas et al., 2006), suggesting
that the situation is complex. Further studies with larger sample sizes
are needed to further replicate our ﬁndings.
We only observed slightly greater improvements (not signiﬁcant) in
standard acupuncture as compared to TAU controls after 10 acu-
puncture treatments. This may be due to the small sample size in this
study. The result is consistent with a recent acupuncture clinical trial on
knee OA in which the authors found that acupuncture treatments only
produced mild improvements in knee pain compared with no acu-
puncture controls (Hinman et al., 2014b). This result is also in line with
a recent osteoarthritis care and management guideline that does not
recommend acupuncture treatment for OA (https://www.nice.org.uk/
guidance/cg177/chapter/1-Recommendations#non-pharmacological-
management-2). Most importantly, our results endorse the robustness
of expectation in modulating treatment eﬀects, and its potential to
improve clinical practice.
Multiple neurocognitive constructs have been used to theorize about
potential mechanisms for how expectation can modulate one's pain
experience. One such construct works through the reward circuitry,
which includes the dopaminergic pathways from the NAc and its con-
nections with the opioid rich ACC (Navratilova et al., 2015a). Pain and
reward are both powerful motivators of behavior that share neuroa-
natomical substrates (Leknes and Tracey, 2008). Pain is usually con-
sidered to be the opposite of pleasure; thus, relief of pain can be re-
garded as a special case of reward. Scott and colleagues (Scott et al.,
2007) found that the release of dopamine from the NAc plays a crucial
role in the expectancy modulation of pain. Wanigasekera et al.
(Wanigasekera et al., 2012) found that individuals with high reward
responsiveness, a personality trait dependent on endogenous opioid
neurotransmission, experience more exogenous remifentanil-induced
behavioral analgesia. Becker and colleagues found that pain relief en-
gages endogenous pain-inhibitory pathways when obtained in a moti-
vated state, which might be used to improve pain treatment by a po-
sitive and self-amplifying feedback loop (Becker et al., 2015).
The role of the reward/motivation circuitry in mediating enhanced
treatment outcomes due to expectation of analgesia is also supported by
a study in which (Lee et al., 2015) acupuncture needle stimulation was
associated with the verbal suggestion that treatment will be eﬀective.
This association with positive verbal suggestion produced greater fMRI
signal increases at the ventral striatum, including the NAc, as compared
to pure needle stimulation given without the verbal suggestion. In an-
other study, Li and colleagues (Li et al., 2016) found rsFC changes
between the PAG and the NAc, as well as the MPFC/rACC before and
after one-month of acupuncture treatment were signiﬁcantly associated
with migraine headache intensity relief. Although we did not observe
the NAc and PAG connectivity changes at the threshold we set, we
found increased NAc – PAG and surrounding area increases in the
boosted acupuncture group compared to standard acupuncture group at
a liberal threshold (p < 0.05 voxel-wise). We speculate this is due to
the relatively small sample size of this study. Taken together, these
studies support the important role of the NAc in expectancy modulation
and acupuncture treatment.
In our study, we found signiﬁcant rsFC increases between the NAc
and MPFC/rACC. Studies suggest that the rACC/MPFC is a key region in
the descending pain modulatory system (Eippert and Tracey, 2014;
Fields, 2004; Jensen et al., 2012; Kong et al., 2013a; Kucyi et al., 2013;
Tracey et al., 2002; Yu et al., 2014a), forming a core network with the
PAG and rostral ventral medulla (RVM) (Kong et al., 2010). Studies
show that the rACC/MPFC is involved in the self-regulation of pain such
as placebo analgesia (Petrovic et al., 2002 #1445; Kong et al., 2006
#1775; Eippert et al., 2009 #2373; Kong et al., 2007a, 2007b #2006;
Kong et al., 2013a, 2013b #2921) and acupuncture treatment of
chronic pain (Chen et al., 2015; Chen et al., 2014; Egorova et al., 2015a;
Li et al., 2016) and depression (Wang et al., 2016). A recent study
Table 3
NAc rsFC change (post-treatment minus pre-treatment) diﬀerences among the three treatment groups.
Comparison Brain Region Cluster Size MNI Peak (X, Y, Z) Z Value
Boosted > Standard Left MCC 1027 −12 −12 36 4.54
Left paracentral gyrus −10 −16 66 4.09
Left postcentral gyrus −34 −42 72 3.89
Left MPFC/rACC 695 −4 40 32 4.48
Right postcentral gyrus 445 4 −42 80 3.69
Left DLPFC 749 −30 18 26 3.68
Standard > Boosted None
Boosted > TAU Left MPFC 616 −6 40 32 4.88
TAU > Boosted None
Standard > TAU None
TAU > Standard None
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(Baliki et al., 2012) found that greater functional connectivity of the
NAc with the MPFC/ACC can predict the development of sub–acute
back pain patients. A more recent study (Brown et al., 2015) found that
compared to healthy controls, patients with arthritis pain had overall
less opioid receptor availability within the striatum. Previous studies
propose that the MPFC/rACC, supported by the putamen, provides an
expected value-related input to the PAG, which then conveys aversive
prediction error signals to regulate behavior (Eippert and Tracey, 2014;
Roy et al., 2014). Thus, enhanced NAc and rACC/MPFC rsFC suggests
that boosted expectancy may work by strengthening the descending
pain modulation system.
There are several limitations in this manuscript. First, we did not
measure the knee pain intensity during the fMRI scan systemically.
Nevertheless, all patients reported they did not experience or only ex-
perienced very mild knee pain while they were lying in the scanner.
Secondly, we did not include the duration of the patients' knee pain in
the manuscript since most patients could not give an accurate starting
time of the knee pain. We suspect our randomization adjusted for this
potential confound.
In conclusion, we found that the boosted expectation of acupuncture
analgesia in response to experimental pain can be transferred to clinical
pain, which can in turn enhance the acupuncture treatment eﬀect for
chronic pain in patients with knee OA. Boosted expectation sig-
niﬁcantly strengthens the rsFC between the reward/motivation system,
descending pain modulation system, and sensory and aﬀective pain
processes to enhance the acupuncture treatment eﬀect. Elucidation of
these brain processes may shed light on how to enhance treatment
outcomes of pharmacological and various integrative medicines in
clinical settings.
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.nicl.2018.01.021.
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